Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A

References

• Tan NC, Chan LL, Tan EK. Hemifacial spasm and involuntary facial movements. QJM. 2002;95(8):493–500. doi:10.1093/qjmed/95.8.493
   PubMed Web of Science ®Google Scholar
• Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna). 2008;115(4):585–591. doi:10.1007/s00702-007-0768-7
   Web of Science ®Google Scholar
• Chaudhry N, Srivastava A, Joshi L. Hemifacial spasm: the past, present and future. J Neurol Sci. 2015;356(1–2):27–31. doi:10.1016/j.jns.2015.06.032
   PubMed Web of Science ®Google Scholar
• Sorgun MH, Yilmaz R, Akin YA, Mercan FN, Akbostanci MC. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015;22(8):1319–1325. doi:10.1016/j.jocn.2015.02.032
   PubMed Web of Science ®Google Scholar
• Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm. Sci Rep. 2018;8(1):8367. doi:10.1038/s41598-018-26750-5
   PubMed Web of Science ®Google Scholar
• Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A. Outcome predictors, efficacy and safety of botox and dysport in the long-term treatment of hemifacial spasm. Eur J Neurol. 2009;16(3):392–398. doi:10.1111/j.1468-1331.2008.02507.x
   PubMed Web of Science ®Google Scholar
• Ho RW, Fang PC, Chang CH, Liu YP, Kuo MT. A review of periocular botulinum neurotoxin on the tear film homeostasis and the ocular surface change. Toxins (Basel). 2019;11(2):66. doi:10.3390/toxins11020066
   Web of Science ®Google Scholar
• Alsuhaibani AH, Eid SA. Botulinum toxin injection and tear production. Curr Opin Ophthalmol. 2018;29(5):428–433. doi:10.1097/ICU.0000000000000506
   Web of Science ®Google Scholar
• Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O. Corneal and tear film changes after botulinum toxin-A in blepharospasm or hemifacial spasm. Cornea. 2015;34(8):906–910. doi:10.1097/ICO.0000000000000482
   Web of Science ®Google Scholar
• Ziak P, Halicka J, Kapitanova K, Mojzis P. Effect of botulinum toxin A application in neuro-ophtalmologic indications on schirmers test and tears osmolarity. Cesk Slov Oftalmol. 2019;75(2):74–77. doi:10.31348/2019/2/3
   Google Scholar
• Pellegrini M, Schiavi C, Taroni L, et al. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: a Comparative Fellow Eye Study. Indian J Ophthalmol. 2019;67(9):1405–1409. doi:10.4103/ijo.IJO_41_19
   Web of Science ®Google Scholar
• Park DI, Shin HM, Lee SY, Lew H. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Acta Ophthalmol. 2013;91(2):e108–112. doi:10.1111/aos.12002
   PubMed Web of Science ®Google Scholar
• Mali YP, Schultze RL, Wladis EJ. Evaluating the effects of botulinum toxin A on tear metrics in patients with hemifacial spasm. Orbit. 2017;36(5):307–310. doi:10.1080/01676830.2017.1337164
   PubMed Web of Science ®Google Scholar
• Horwath-Winter J, Bergloeff J, Floegel I, Haller-Schober EM, Schmut O. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye. Br J Ophthalmol. 2003;87(1):54–56. doi:10.1136/bjo.87.1.54
   PubMed Web of Science ®Google Scholar
• Lu R, Huang R, Li K, et al. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. Am J Ophthalmol. 2014;157(3):591–597.e591–592. doi:10.1016/j.ajo.2013.11.014
   Web of Science ®Google Scholar
• Kocabeyoglu S, Sekeroglu HT, Mocan MC, Muz E, Irkec M, Sanac AS. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection. Eur J Ophthalmol. 2014;24(6):830–834. doi:10.5301/ejo.5000482
   PubMed Web of Science ®Google Scholar
• Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sjogren’s syndrome: a preliminary report. J Rheumatol. 1997;24(9):1842–1843.
   Web of Science ®Google Scholar
• Tsubota K, Fujihara T, Kaido M, Mori A, Mimura M, Kato M. Dry eye and Meige’s syndrome. Br J Ophthalmol. 1997;81(6):439–442. doi:10.1136/bjo.81.6.439
   Web of Science ®Google Scholar
• Gosal JS, Das KK, Khatri D, Attri G, Jaiswal AK. Contralateral dry eye in hemifacial spasm: a new clinical sign. Asian J Neurosurg. 2019;14(3):996–998. doi:10.4103/ajns.AJNS_48_19
   Google Scholar
• Raj A, Arya SK, Deswal J, Bamotra RK. Five-year retrospective review of cases with benign essential blepharospasm and hemifacial spasm presenting in a tertiary eye care center in North India. Semin Ophthalmol. 2017;32(3):371–376. doi:10.3109/08820538.2015.1096401
   PubMed Web of Science ®Google Scholar
• Price J, O’Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol. 1993;13(1):67–71.
   Google Scholar
• Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009;24(3):407–413. doi:10.1002/mds.22368
   PubMed Web of Science ®Google Scholar
• Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128(1):94–101. doi:10.1001/archophthalmol.2009.356
   PubMedGoogle Scholar
• Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008
   PubMed Web of Science ®Google Scholar
• Maskin SL. Effect of ocular surface reconstruction by using amniotic membrane transplant for symptomatic conjunctivochalasis on fluorescein clearance test results. Cornea. 2008;27(6):644–649. doi:10.1097/01.ico.0000611376.96794.01
   Web of Science ®Google Scholar
• Tsubota K, Yokoi N, Shimazaki J, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia dry eye society. Ocul Surf. 2017;15(1):65–76. doi:10.1016/j.jtos.2016.09.003
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Shiraishi A. Relationship between eyelid pressure and ocular surface disorders in patients with healthy and dry eyes. Invest Ophthalmol Vis Sci. 2018;59(14):Des56–des63. doi:10.1167/iovs.17-23586
   Web of Science ®Google Scholar
• Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117:28–38. doi:10.1016/j.exer.2013.08.010
   PubMed Web of Science ®Google Scholar